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Symptomatic long QT syndrome in pediatric patients is a life-threatening condition.
Sometimes, this pathology can be misdiagnosed and erroneously managed as generalized
epilepsy due to similar clinical manifestations. The presented case discusses a 13-year-old
female patient with generalized epilepsy since the age of 4, admitted for two episodes of
resuscitated cardiac arrest due to torsades de pointes and ventricular ﬁbrillation. The ﬁnal
diagnosis of congenital long QT was established and due to the patient's high-risk proﬁle
for future cardiac events, implantable cardiac deﬁbrillator was subsequently indicated.
Early recognition of congenital long QT and timing of cardiac therapy were crucial and
potentially lower the incidence of fatal dysrhythmias commonly associated this condition.
In high-risk patients, both medical and interventional therapy can be life-saving.1. Introduction
Congenital long QT syndrome (LQTS) is a genetic chan-
nelopathy characterized by delayed ventricular repolarization
predominantly reﬂected on the electrocardiogram (ECG) as QT
interval prolongation.
This speciﬁc condition predisposes to potentially fatal dys-
rhythmias such as ventricular ﬁbrillation or torsades de pointes
(TrP) clinically manifesting as syncope and seizures and leading
to sudden cardiac death (SCD) in young and undiagnosed
patients.
2. Case presentation
In April 2015, a 13-year-old female patient with a history of
generalized epilepsy since the age of 4, with previous neurologictreatment including two anti-epileptic drugs (valproate and lev-
etiracetam) was referred to the emergency department for further
investigations. She presented two recent episodes of resuscitated
cardiac arrest due to TrP (Figure 1), manifested as seizures and
syncope described by the patient and its' family as no different as
the other previous grand mal epileptic attacks.
The patient mentioned that the current episodes (2 days
before admission) occurred during daily activity combined with
high emotional state and was preceded by palpitations. She re-
ported no personal history of cardiovascular disease or risk
factors, but family history revealed SCD in her older sister at the
age of 15.
To note, the previous anti-epileptic treatment failed to control
the periodical attacks.
The clinical evaluation upon admission described normal
cardiovascular, respiratory and central nervous system exami-
nations and no detectable heart or vascular bruits. Blood pres-
sure was 100/60 mmHg and the heart rate was 98 beats/min. The
chest X-ray and laboratory ﬁndings ranged within normal limits.
An ECG tracing revealed prolonged QT and corrected QT (QTc)
interval (Figure 2).
Transthoracic echocardiography identiﬁed no cardiac struc-
tural abnormalities (including cardiac congenital anomalies),ccess article under the CC BY-NC-ND license
Figure 1. Episodes of TrP before admission.
Figure 3. The ECG from patient's mother (QTc prolongation of 484 ms
and incomplete right bundle block).
Figure 4. ECG trace during thoracic pain (long QT interval and asym-
metrically peaked T wave).
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signiﬁcant valvulopathies.
ECG traces were obtained in all immediate family members.
Prolonged QTc was identiﬁed in the patient's mother (Figure 3),
while the father and brother presented a normal ECG pattern.
3. In-hospital course
In an attempt to minimize the possibility of long QT iatro-
genic potentiating, both anti-epileptic drugs (valproate andFigure 2. ECG upon admission.
Normal sinus rhythm, prolonged QT interval and a T-U complex as well as bro
612 ms using the Bazett correction.levetiracetam) were considered for their effects upon cardiac
repolarization, though no robust evidence-base data support
association between these drugs and QT prolongation.
The patient reported very few symptoms during hospitaliza-
tion including intermittent thoracic pain during emotional stress
and anxiety. Concomitant ECG tracing described no particular
ischemic changes but a rather different LQTS pattern was shown
above (Figure 4).ad-based T wave were described. The rate-corrected QT interval (QTc) was
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implanted without any notable per-procedural complications.
One month after discharge, the patient's ECG was ambula-
tory monitored for 24 h and revealed an average ventricular rate
of 70 beats/min (under beta-blocker and valproate treatment).
The ICD interrogation revealed no speciﬁc dysrhythmias. ICD
monitoring and close clinical follow-up of the patient were
recommended at 3, 6 and 12 months.
4. Discussion
The above presented case offers the speciﬁc clinical spectrum
of manifestations: symptoms' onset at the age of 4 (seizures and
syncope that spontaneously remitted in the past), unrecognized
ECG changes, unsuccessfully treated epilepsy with repeated
cardiac arrest due to TrP and ventricular ﬁbrillation preceded by
palpitations. Unicameral ICD was subsequently implanted in
order to reduce future cardiovascular risk.
Congenital LQTS is a familial inherited disorder with spe-
ciﬁcally variable penetration (mainly autosomal dominant while
recessive forms are not uncommon) caused by gene mutations
that encode sodium, calcium and potassium cardiac channels[1].
Over the last years, the effort to understand the underlying
genetic mechanisms of cardiac action potential disturbances
leading to these fatal repolarization disorders offered a new
perspective upon diagnostic, risk stratiﬁcation, treatment options
and family screening directed to reduce the commonly associ-
ated cardiac death.
Long QT 1 (LQT1) is known to be caused by the mutations
of genes encoding the slow component of the potassium current.
Still, when it comes to epilepsy associated with LQTS 1, the
molecular mechanisms remain unclear. Sudden unexplained
death in epilepsy is a recognized event among patients with
epilepsy (17% prevalence)[2]. In addition, KCNQ1 expression (a
component of potassium current channels) in forebrain neuronal
networks and brainstem nuclei (regions in which anomalies of
neurons repolarization after an action potential can produce
seizures and dysrhythmias) was demonstrated. These recent
ﬁndings underline the dual arrhythmogenic potential of an ion
channelopathy co-expressed in the heart and brain and a
possible relationship between epilepsy and LQT1[3].
It is conﬁrmed by literature reports that the ST-T segment's
morphology has been successfully used in predicting the speciﬁc
genotype of LQTS, a feature particularly important for the
subsequent genetic analysis in the majority of cases[4,5]. This
information is clearly important considering that extensive
genetic testing is not possible in LQTS patients (15 distinct
LQTS-susceptibility genes and hundreds of gene' mutations
described so far)[6]. Targeted genetic testing after clinically
suspecting a certain genotype seems to be a more appropriate
strategy. Up to 80% of the LQTS cases are correctly identiﬁed
based on ECG ﬁndings[4].
Genetic testing has been largely used as it may increase
diagnostic sensitivity and increase diagnostic accuracy in
borderline cases[1]. However, a subsequent negative genetic test
in these patients does not exclude LQTS[7]. When the genetic
approach is not available, ECG remains the most useful, cheap
and highly available diagnostic tool in LQTS.
In this case, we ﬁrstly assessed the ECG patterns in order to
establish the type of LQTS. Generally, LQTS type 1 is deﬁned by
broad-based, peaked/asymmetrical T wave particularly in pre-
cordial leads, but normal or late-onset normal T wave are notuncommon. The mainly described pattern in LQTS 2 is of biﬁd/
low amplitude T wave, while late-onset peaked or asymmetrical
peaked T wave is the hallmark for LQTS 3[4]. Noteworthy, we
encountered both LQTS 1 and 3 patterns in our case as presented.
As theECGpatterns could resemble the two types of LQTS, the
clinical presentation in such cases should be considered as the
conditions that trigger most of the cardiac events which are gene-
speciﬁc, suggesting that life-threatening dysrhythmias may occur
under speciﬁc circumstances. Recent studies demonstrated that
exercise was the speciﬁc triggering in 62% of LQTS 1, signiﬁ-
cantly contrasting with 13% in LQTS 2 and LQTS 3[8]. Also, the
appearance of lethal cardiac events while exercising was present
in 68% of the cases in LQTS 1 when compared to 4% in LQTS
3 patients, which showed a rather high prevalence of lethal
events during sleep and rest (39%). Additionally, LQT1 patients
tend to develop symptoms earlier than LQT2 and LQT3, almost
54% of them being symptomatic before the age of 10[8].
Based on clinical presentation, familial history and ECG
abnormalities, current diagnosis of type 1 LQTS was established
and beta-blocker therapy was immediately considered.
One of the strongest predictors in assessing future life-
threatening cardiac events in LQTS patient is the history of
syncope (frequency and timing). More than 2 episodes during
the last 2 years (age between 10 and 20) include the patient in
the high-risk category, future potentially deadly cardiac events
(18-fold increased risk by comparison to those without epi-
sodes)[9]. Moreover, a history of aborted cardiac arrest and ECG-
documented episodes of TrP sustain the high-risk category based
on the published mortality rates in the ﬁeld[10].
The decision for ICD in the presented case was based on a
clear history of life-threatening cardiac arrhythmias, frequent
syncope, history of previous familial SCD and established
diagnosis of congenital LQTS.
Due to the high clinical resemblance, general epilepsy could
mask SCD in young patients with previously undiagnosed
congenital LQTS. The presented case emphasized the need to
correctly diagnose this disease otherwise treatable, lethal
condition.
It was also highlighted the importance of a multidisciplinary
team (pediatric, neurologist, cardiologist) in assessing young
patients presenting syncope and seizures.
Written informed consent was obtained from the patient for
publication of this case report and accompanying images.
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